Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.
Lin J, Liu J, Hao SG, Lan B, Zheng XB, Xiong JN, Zhang YQ, Gao X, Chen CB, Chen L, Huang YF, Luo H, Yi YT, Yi X, Lu JP, Zheng XW, Chen G, Wang XF, Chen Y. Lin J, et al. Among authors: zheng xw, zheng xb. Front Immunol. 2022 Nov 23;13:1022598. doi: 10.3389/fimmu.2022.1022598. eCollection 2022. Front Immunol. 2022. PMID: 36505399 Free PMC article.
Role of PRKDC in cancer initiation, progression, and treatment.
Chen Y, Li Y, Xiong J, Lan B, Wang X, Liu J, Lin J, Fei Z, Zheng X, Chen C. Chen Y, et al. Cancer Cell Int. 2021 Oct 26;21(1):563. doi: 10.1186/s12935-021-02229-8. Cancer Cell Int. 2021. PMID: 34702253 Free PMC article. Review.
Heterogeneity of tumor immune microenvironment and real-world analysis of immunotherapy efficacy in lung adenosquamous carcinoma.
Li C, Zheng X, Li P, Wang H, Hu J, Wu L, Wang Z, Guo H, Wu F, Zhong W, Zhou C, Chu Q, Zhao J, Zheng X, Xiao W, Zhu W, Zhang L, Li Q, Jiang K, Miao Q, Wu B, Xu Y, Wu S, Wang H, Yang S, Li Y, Xia X, Yi X, Huang C, Zhu B, Lin G. Li C, et al. Front Immunol. 2022 Aug 12;13:944812. doi: 10.3389/fimmu.2022.944812. eCollection 2022. Front Immunol. 2022. PMID: 36032124 Free PMC article.
CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types.
Zheng X, Jiang K, Xiao W, Zeng D, Peng W, Bai J, Chen X, Li P, Zhang L, Zheng X, Miao Q, Wang H, Wu S, Xu Y, Xu H, Li C, Li L, Gao X, Zheng S, Li J, Wang D, Zhou Z, Xia X, Yang S, Li Y, Cui Z, Zhang Q, Chen L, Lin X, Lin G. Zheng X, et al. Front Immunol. 2022 Nov 9;13:974265. doi: 10.3389/fimmu.2022.974265. eCollection 2022. Front Immunol. 2022. PMID: 36439099 Free PMC article.
173 results